Acura Pharm Stock Price, News & Analysis
Company Description
Acura Pharm (OTC Link: ACUR) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $33.0K.
ACUR stock has declined 49.5% over the past year. Shares last traded at $0.0100.
On a trailing twelve-month basis, Acura Pharm reported revenue of $1.6M with net income of -$879K and diluted earnings per share of $-0.02. The company operates at a net profit margin of -56.2%.
This page provides a comprehensive overview of ACUR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Acura Pharm (ACUR) stock last traded at $0.0100. Over the past 12 months, the stock has lost 49.5%. At a market capitalization of $33.0K, ACUR is classified as a micro-cap stock with approximately 66.3M shares outstanding.
Latest News
Acura Pharm has 9 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings. View all ACUR news →
SEC Filings
Acura Pharm has filed 5 recent SEC filings, including 3 Form 4, 2 Form 8-K. The most recent filing was submitted on March 10, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ACUR SEC filings →
Financial Highlights
Acura Pharm generated $1.6M in revenue over the trailing twelve months, operating income reached -$1.2M (-77.7% operating margin), and net income was -$879K, reflecting a -56.2% net profit margin. Diluted earnings per share stood at $-0.02. The company generated -$742K in operating cash flow. With a current ratio of 0.72, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Acura Pharm (ACUR) currently stands at 6.3 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 26.1 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Acura Pharm (ACUR) currently stands at 26.1 days, up 602.7% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 413.2% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
ACUR Company Profile & Sector Positioning
Acura Pharm (ACUR) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ACUR often look at related companies in the same sector, including Panacea Life Sciences Hldgs Inc (PLSH), Nunzia Pharmaceutical Corp (NUNZ), Cbd Life Science (CBDL), Genix Pharmaceut (GENPF), and Allied (ALID). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ACUR's relative position within its industry.